Paper8109916
Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.
Chen M and 7 others. Antimicrob Agents Chemother, 1993. Cited by 140 papers, by iCite.
Cite this record
ConductScience Library. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania. Papers, record 8109916. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8109916
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiprotozoal Agents | Major topic |
| Chalcone | Major topic |
| Leishmania donovani | Major topic |
| Leishmania major | Major topic |
| Leishmaniasis, Cutaneous | Major topic |
| Leishmaniasis, Visceral | Major topic |
| Plant Extracts | Major topic |
| Animals | |
| Chalcones | |
| Dose-Response Relationship, Drug | |
| Drugs, Chinese Herbal | |
| Humans | |
| Leukocytes | |
| Macrophages | |
| Mice | |
| Mice, Inbred BALB C |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1956959 | Antiprotozoal agents from plant sources. | Planta Med | 1991 | https://conductscience.org/library/papers/1956959 | PubMed |
| 2 | 196028 | Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniases. | J Infect Dis | 1977 | https://conductscience.org/library/papers/196028 | PubMed |
| 3 | 3787684 | Effect of chloroquine on human lymphocyte proliferation. | Trans R Soc Trop Med Hyg | 1986 | https://conductscience.org/library/papers/3787684 | PubMed |
| 4 | 2360830 | Berberine derivatives as antileishmanial drugs. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2360830 | PubMed |
| 5 | 6638989 | Activity of purine analogs against Leishmania tropica within human macrophages in vitro. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6638989 | PubMed |
| 6 | 3124733 | Molecular target of the antileishmanial action of sinefungin. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3124733 | PubMed |
| 7 | 2392684 | Inhibition of leishmanias but not host macrophages by the antitubulin herbicide trifluralin. | Science | 1990 | https://conductscience.org/library/papers/2392684 | PubMed |
| 8 | 3293160 | Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies. | Rev Infect Dis | 1988 | https://conductscience.org/library/papers/3293160 | PubMed |
| 9 | 1898600 | Macrophage activation for intracellular killing as induced by calcium ionophore. Correlation with biologic and biochemical events. | J Immunol | 1991 | https://conductscience.org/library/papers/1898600 | PubMed |
| 10 | 15463585 | Estimation of population at risk of infection and number of cases of Leishmaniasis. | Parasitol Today | 1992 | https://conductscience.org/library/papers/15463585 | PubMed |
| 11 | 3014012 | Growth of Leishmania donovani amastigotes in the continuous human macrophage cell line U937: studies of drug efficacy and metabolism. | J Infect Dis | 1986 | https://conductscience.org/library/papers/3014012 | PubMed |
| 12 | 1738379 | Allopurinol in the treatment of American cutaneous leishmaniasis. | N Engl J Med | 1992 | https://conductscience.org/library/papers/1738379 | PubMed |
| 13 | 3435106 | In vitro activity of sulfonamides and sulfones against Leishmania major promastigotes. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3435106 | PubMed |
| 14 | 1906917 | Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. | J Lab Clin Med | 1991 | https://conductscience.org/library/papers/1906917 | PubMed |
| 15 | 6249874 | An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. | J Infect Dis | 1980 | https://conductscience.org/library/papers/6249874 | PubMed |
| 16 | 2605703 | Identification of antimicrobial and antioxidant constituents from licorice of Russian and Xinjiang origin. | Chem Pharm Bull (Tokyo) | 1989 | https://conductscience.org/library/papers/2605703 | PubMed |
| 17 | 2632045 | Phenolic constituents of licorice. II. Structures of licopyranocoumarin, licoarylcoumarin and glisoflavone, and inhibitory effects of licorice phenolics on xanthine oxidase. | Chem Pharm Bull (Tokyo) | 1989 | https://conductscience.org/library/papers/2632045 | PubMed |
| 18 | 6712205 | Biological action of inosine analogs in Leishmania and Trypanosoma spp. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6712205 | PubMed |
| 19 | 6732225 | Antileishmanial activity of chlorpromazine. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6732225 | PubMed |
| 20 | 6327528 | Pseudomonas aeruginosa exoproteases inhibit human neutrophil chemiluminescence. | Infect Immun | 1984 | https://conductscience.org/library/papers/6327528 | PubMed |
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42357280 | Cross-Species Hepatic Metabolism of the Antileishmanial Chalcone NAT22 Generates Metabolites with Predicted Enhanced Affinity for the Parasite Target cTXNPx. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42357280 | PubMed |
| 41181588 | Therapeutic potential of Licochalcone A in dermatological diseases: from basic to clinical research. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41181588 | PubMed |
| 41155147 | Recent Advances in the Synthesis and Biological Applications of Prenylated Chalcones. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155147 | PubMed |
| 40599794 | Pharmacological potential of natural chalcones: a recent studies and future perspective. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40599794 | PubMed |
| 40284397 | Nanocrystallization Effectively Improves the Oral Efficacy of an Antileishmanial Chalcone. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40284397 | PubMed |
| 39650850 | Identification of Coumarin-Chalcone and Coumarin-Pyrazoline Derivatives as Novel Anti-Toxoplasma gondii Agents. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/39650850 | PubMed |
| 38937401 | Significance of Chalcone Scaffolds in Medicinal Chemistry. | Top Curr Chem (Cham) | 2024 | https://conductscience.org/library/papers/38937401 | PubMed |
| 38303536 | An Insight into Synthetic Strategies, SAR Study and Anticancer Mechanism of Chalcone Derivatives: Medicinal Chemistry Perspective. | Curr Drug Res Rev | 2025 | https://conductscience.org/library/papers/38303536 | PubMed |
| 36827107 | Salt-Tolerant Plants as Sources of Antiparasitic Agents for Human Use: A Comprehensive Review. | Mar Drugs | 2023 | https://conductscience.org/library/papers/36827107 | PubMed |
| 36474507 | Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects. | Onco Targets Ther | 2022 | https://conductscience.org/library/papers/36474507 | PubMed |
| 36306047 | Synthesis, characterization and evaluation of prenylated chalcones ethers as promising antileishmanial compounds. | Mol Divers | 2023 | https://conductscience.org/library/papers/36306047 | PubMed |
| 36296655 | Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives. | Molecules | 2022 | https://conductscience.org/library/papers/36296655 | PubMed |
| 35744875 | Synthesis and Characterization of Novel Heterocyclic Chalcones from 1-Phenyl-1H-pyrazol-3-ol. | Molecules | 2022 | https://conductscience.org/library/papers/35744875 | PubMed |
| 35493668 | Synthesis and in vitro anti-proliferative evaluation of naphthalimide-chalcone/pyrazoline conjugates as potential SERMs with computational validation. | RSC Adv | 2020 | https://conductscience.org/library/papers/35493668 | PubMed |
| 35434631 | Identification of 2-arylquinazolines with alkyl-polyamine motifs as potent antileishmanial agents: synthesis and biological evaluation studies. | RSC Med Chem | 2022 | https://conductscience.org/library/papers/35434631 | PubMed |
| 34977998 | Antimalarial Natural Products. | Prog Chem Org Nat Prod | 2022 | https://conductscience.org/library/papers/34977998 | PubMed |
| 34660960 | Synthesis, Structural Characterizations, and Quantum Chemical Investigations on 1-(3-Methoxy-phenyl)-3-naphthalen-1-yl-propenone. | ACS Omega | 2021 | https://conductscience.org/library/papers/34660960 | PubMed |
| 34187608 | Moringa oleifera extract promotes apoptosis-like death in Toxoplasma gondii tachyzoites in vitro. | Parasitology | 2021 | https://conductscience.org/library/papers/34187608 | PubMed |
| 33536909 | Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33536909 | PubMed |
| 33363224 | Licochalcone a Exhibits Leishmanicidal Activity in vitro and in Experimental Model of Leishmania (Leishmania) Infantum. | Front Vet Sci | 2020 | https://conductscience.org/library/papers/33363224 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8109916
GET https://conductscience.org/api/papers/v1/8109916/references?page=2